15.36
3.21%
-0.51
Handel nachbörslich:
15.36
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.92%
22.32
|
25.63 | 23.96 | 16.01 | 14.33 |
Operating Income/Loss |
12.92%
-22.32
|
-25.63 | -23.96 | -16.01 | -14.33 |
Nonoperating Income/Loss |
47.29%
4.13
|
2.804 | 2.811 | 2.742 | 2.454 |
Income/Loss From Continuing Operations Before Tax |
20.32%
-18.19
|
-22.83 | -21.15 | -13.27 | -11.88 |
Income/Loss From Continuing Operations After Tax |
20.32%
-18.19
|
-22.83 | -21.15 | -13.27 | -11.88 |
Net Income/Loss
|
20.32%
-18.19
|
-22.83 | -21.15 | -13.27 | -11.88 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
60,772%
52.23
|
0.0858 | 42.87 | 42.59 | 42.39 |
Diluted Average Shares |
60,772%
52.23
|
0.0858 | 42.87 | 42.59 | 42.39 |
Basic Earnings Per Share |
33.96%
-0.35
|
-0.53 | -0.49 | -0.31 | -0.28 |
Diluted Earnings Per Share |
33.96%
-0.35
|
-0.53 | -0.49 | -0.31 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):